CMOTEC B — Scandinavian ChemoTech AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK34.20m
- SEK33.25m
- SEK6.57m
Annual cashflow statement for Scandinavian ChemoTech AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | PRESS |
| Standards: | — | — | — | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | -17.1 | -20.9 | -20.2 | — |
| Depreciation | |||||
| Non-Cash Items | — | 0.055 | 0.409 | -0.249 | — |
| Unusual Items | |||||
| Changes in Working Capital | -11.5 | -4.98 | -1.93 | -0.42 | -13.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.5 | -19.2 | -19.5 | -18.2 | -13.1 |
| Capital Expenditures | — | -3.18 | -0.331 | -0.68 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.83 | -0.15 | -0.272 | 0.212 | -0.002 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.83 | -3.33 | -0.603 | -0.468 | -0.002 |
| Financing Cash Flow Items | 12 | — | — | — | 13.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12 | 29.7 | 17.3 | 13.8 | 13.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.38 | 7.2 | -2.83 | -4.93 | 0.026 |